CTRI/2012/05/002654招募中2 期
Clinical Evaluation of Rasayana Effect of Ashwagandhadi Lehya in Apparently Healthy Elderly Persons. - ACT- RAS-2010
Department of AYUSH Ministry of Health Family Welfare Government of India0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Apparently Healthy Males / Females of age between 50 and 75 years
- •2. Willing and able to participate for 16 weeks
排除标准
- •1. Patients with evidence of malignancy
- •2. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, etc.)
- •3. Patients who have a past history of Atrial Fibrillation, Coronary Artery Disease (CAD), Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •4. Symptomatic patient with clinical evidence of Heart failure.
- •5. Patients with poorly controlled Hypertension ( > 160 / 100 mm Hg)
- •6. Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
- •7. Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL).
- •8. Patients with severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), Inflammatory Bowel Disease, Severe Dementia, Severe Infection(s), Non-ambulatory patient or any other condition that may jeopardize the study.
- •9. Prostate Specific Antigen (PSA) levels > 4 ng/mL
- •10. Alcoholics and/or drug abusers.
- •11. Pregnant / lactating woman
- •12 Patients suffering from Diabetes Mellitus {B.S. (F) > 126 mg% and / or B.S. (2 hr. PP) >200 mg% or HbA1c > 6.5%}.
- •13 H/o hypersensitivity to the trial drug or any of its ingredients.
- •14 Patients who have completed participation in any other clinical trial during the past six (06) months.
- •15 Any other condition which the Principal Investigator thinks may jeopardize the study.
研究者
相似试验
招募中
2 期
A clinical study to see the effect of an Ayurvedic formulation in the Elderly.CTRI/2012/03/002535Central Council for Research in Ayurvedic Sciences CCRAS150
尚未招募
2 期
Evaluate the effect of Rasanjanadi Aschyotan in netra Abhishyand w.s.r. to Infective Conjunctivitis.CTRI/2023/09/057326Principal R.G.G.P.G.Ayurvedic College And Hospital,Paprola
进行中（未招募）
2 期
Rasayana effect of Bharangi Guda in patients who were affected and recovered by COVID19CTRI/2022/01/039728DR ROOPA
尚未招募
3 期
Ksheerbala Taila Matra Basti and Ashwagandha Ghritas Treatment in The Spastic Cerebral Palsy IN ChildreCTRI/2022/09/045479niversity Post Graduate Institute of Ayurved Studies and Research Jodhpur Rajasthan
尚未招募
1 期
A study of Ashwagandha Kshaar on cough in children.CTRI/2022/03/041521Department of Kaumarabhritya Shri Narayan Prasad Awasthi Govt Ayurveda College Raipur C G